Scholarly Index
Dennis J. Slamon
University of California, Los Angeles; 99,347 total citations; 564 total publications; best world rank #11
University of California, Los Angeles
99,347Total citations
564Total publications
125H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HER2/EGFR in Cancer Research | Lifetime | 11 | US 6 | 99.92 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 34 | US 25 | 99.89 |
| Advanced Breast Cancer Therapies | Lifetime | 13 | US 5 | 99.82 |
| Cancer Treatment and Pharmacology | Lifetime | 47 | US 26 | 99.81 |
| Cancer-related Molecular Pathways | Lifetime | 56 | US 37 | 99.68 |
| Peptidase Inhibition and Analysis | Lifetime | 115 | US 55 | 99.44 |
| Breast Cancer Treatment Studies | Lifetime | 302 | US 153 | 99.02 |
| T-cell and Retrovirus Studies | Lifetime | 228 | US 115 | 97.53 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 666 | US 361 | 95.21 |
| Cancer-related Molecular Pathways | 2021-2025 | 27 | US 16 | 97.69 |
| Advanced Breast Cancer Therapies | 2021-2025 | 52 | US 22 | 99.06 |
| HER2/EGFR in Cancer Research | 2021-2025 | 100 | US 35 | 98.44 |
| Cancer Treatment and Pharmacology | 2021-2025 | 164 | US 51 | 96.86 |
| Breast Cancer Treatment Studies | 2021-2025 | 294 | US 97 | 96.74 |
| Barrier Structure and Function Studies | 2021-2025 | 459 | US 128 | 61.46 |